Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors

MeSH terms

• Administration, Intravenous / methods
• Adult
• Antineoplastic Agents / therapeutic use*
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / mortality
• Breast Neoplasms / secondary
• Carcinoma / drug therapy*
• Carcinoma / mortality
• Carcinoma / secondary
• Compassionate Use Trials* / methods
• Endometrial Neoplasms / drug therapy*
• Endometrial Neoplasms / mortality
• Endometrial Neoplasms / secondary
• Female
• Follow-Up Studies
• Humans
• Liver Neoplasms / drug therapy*
• Liver Neoplasms / mortality
• Liver Neoplasms / secondary
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / mortality
• Lung Neoplasms / secondary
• Male
• Middle Aged
• Retrospective Studies
• Sirolimus / analogs & derivatives*
• Sirolimus / therapeutic use
• Survival Analysis
• Treatment Outcome